Professor Samuel Wong is a clinician with training in both Family Medicine and Public Health. He is the Director of the JC School of Public Health and Primary Care and the Associate Dean (Education) of the Faculty of Medicine. He is also the Founding Director of the Thomas Jing Centre for Mindfulness Research and Training.

Professor Wong’s research interests include evaluating and developing mindfulness- based and mental health interventions in primary care; evaluating primary care services and developing primary care service models as well as multimorbidity.  He has published more than 200 original papers in peer-reviewed scientific journals including the Annals of Family Medicine, Psychotherapy and Psychosomatics, British Journal of Psychiatry and JAMA Internal Medicine and has contributed 5 book chapters and co-edited the Oxford Textbook of Public Mental Health published by the Oxford University Press.  He has been appointed by the HKSAR government as a member of the Expert Panel in Primary Healthcare and Non-communicable Disease and the Steering Committee on Primary Healthcare Development.

Dr. Jison Hong was born in South Korea and immigrated to the United States at age 5. She grew up in Kansas City, Missouri, and Overland Park, Kansas, and went to college at NYU. She completed medical school and Internal Medicine residency training at Rutgers medical school in Newark, New Jersey. She served as a Chief Resident for an additional year and then went on to complete her fellowship training in Rheumatology at Stanford University Medical Center and joined the faculty in the division of Immunology & Rheumatology at Stanford in 2014 as a Clinical Assistant Professor. She has a particular interest in gout, for which she is currently leading a value-based care project to improve evaluation and management for this patient population and gives lectures on this topic for the Stanford Cardiology Heart Failure fellowship program as well as a continuing medical education lecture for Stanford primary care providers.

Eugene Yang, MD, MS, FACC, is a Professor of Medicine in the Division of Cardiology at the University of Washington School of Medicine and holds the Carl and Renée Behnke Endowed Professorship for Asian Health. He received his undergraduate and graduate degrees from Stanford and his medical degree from the University of Pennsylvania. He completed his internal medicine residency and fellowships in cardiovascular disease and advanced cardiac imaging at Stanford.

Dr. Yang is chair of the ACC Prevention of Cardiovascular Disease Section, Vice-Chair of the ACC Asia Pacific Scientific Conference, and member of the ACC Annual Scientific Sessions and Lifelong Learning Oversight Committees. He co-chairs the Hypertension Working Group for the ACC Prevention Council. He is the director of the Asian Health Initiative and co-director of the Cardiovascular Wellness and Prevention Program at UW Medicine. His research interests include understanding cardiovascular risk among Asian subgroups and developing new technologies for video-based blood pressure measurement.

Dr. Albert Y. Wu is a board-certified ophthalmologist and a fellowship-trained specialist in oculoplastic and orbital surgery. This specialty is dedicated to caring for the eyelid and other structures around the eye. It is also called ophthalmic plastic and reconstructive surgery.

Dr. Wu focuses his expertise on saving people’s vision. He provides comprehensive, compassionate care for both adults and children with sight-threatening diseases and injuries of the eye and surrounding area. He treats tearing, eyelid drooping, thyroid eye disease, eyelid tumors, and other facial disorders. He also performs facial rejuvenation as well as reconstructive and aesthetic surgery procedures.

Dr. Wu is a national leader in advancing the use of stem cell therapy to treat conditions involving the eye and face. His research explores how stem cells can regenerate a patient’s own tissues for potential transplant. He aims to make regenerative medicine an accepted treatment for people worldwide suffering from eye diseases.

The National Eye Institute funded Dr. Wu’s research to develop stem cell therapies to treat corneal blindness and regenerate the eye's surface. He leads the Stanford Ophthalmic Stem Cell and Regenerative Medicine Laboratory and is developing leading-edge treatments for vision loss and eye disease.

Dr. Jochen Profit graduated University of Freiburg Medical School in Germany and completed his Neonatology, Public Health, and Health Services Research training at Harvard. Since 2013, he has been on faculty at Stanford and is currently a Professor of Pediatrics, as well as Chief Quality Officer of the California Perinatal Quality Care Collaborative, a population-based network of 140 NICUs dedicated to quality excellence.

Dr. Profit’s research focuses on optimizing the quality of neonatal-perinatal health care delivery. For over a decade, his research has received continuous funding from the National Insitute of Health and other federal, foundation, and intramural sources. Dr. Profit has served on various national scientific and professional organizations, including the National Academy of Sciences and the National Institute of Health. 

Meryl Sperling, MD, MA, is a fellow in Maternal-Fetal Medicine at Stanford University. She was previously part of the Japanese Exchange and Teaching Program, where she taught English in rural Japan and subsequently received a Master of Arts in secondary education at Columbia University – Teachers College. She attended Georgetown University School of Medicine and completed her residency at the University of Hawaii. Her research interests include gestational diabetes mellitus and maternal health disparities in Asian American and Pacific Islander populations.

Grace J. Yoo, Ph.D., M.P.H.,  is a Professor and former chair of Asian American studies at San Francisco State University.  She is a medical sociologist with a background in public health who has spent 30 years teaching and researching years about health, illness, and social support among Asian Americans.   She is the co-author with Barbara Kim of Caring across Generations: The Linked Lives of Korean American families (NYU Press), which received the 2015 Asia and Asian America Section Best Book Award from the American Sociological Association.  She is also editor/co-editor of three books, including the Encyclopedia of Asian Americans Today (ABC-Clio) with Edith Chen,  Handbook of Asian American Health (Springer) with Mai-Nhung Le and Alan Oda, and Koreans in America: History, Identity, and Community(Cognella). She has also published widely in journals such as Health Education & Behavior, Supportive Cancer Care, Ethnicity and Disease, and Journal of Immigrant and Minority Health.

Dr. A. Dimitrios Colevas is known in the US and abroad for three areas of expertise 1) multi-modality treatment of head and neck cancer, 2) first-in-human and early clinical trials development with a focus on therapeutics for patients with head and neck cancer, 3) new therapeutics in patients with nasopharyngeal carcinoma. Dr. Colevas has over 25 years of experience with the conduct of clinical trials, oversight of clinical trials, and regulatory aspects governing clinical trials. In addition, he is a long-standing member of the NCCN head and neck panel, a national body that largely determines standards of care in a multidisciplinary way for head and neck cancer. He has been an active member of the National Clinical Trial Networks of ECOG/ACRIN and NRG. He has been a member of the California Cancer Consortium early clinical trials network. He remains active in research, clinical care, and teaching as a professor of medicine at the Stanford Cancer Institute.

Sum Kim, MD, MS, is a board-certified endocrinologist who specializes in the treatment of type 2 diabetes, polycystic ovarian syndrome (PCOS), and obesity. She is particularly devoted to helping individuals change their lifestyles and achieve sustained improvements in their health.

Scarlett Lin Gomez, PhD, is an epidemiologist with research interests in the role of social determinants of health, including race/ethnicity, socioeconomic status, gender, immigration status, sociocultural factors, and neighborhood contextual characteristics, on health outcomes. She is a Professor in the Department of Epidemiology and Biostatistics, Co-Leader of the Cancer Control Program of the Helen Diller Family Comprehensive Cancer Center, and the Director of the Greater Bay Area Cancer Registry, a part of the California Cancer Registry and the NCI Surveillance Epidemiology End Results (SEER) Program.

Iona Cheng, MPH, PhD, Professor, Department of Epidemiology and Biostatistics, UCSF. Dr. Cheng is a cancer epidemiologist with a research program centered on understanding the role of genetics, health behaviors, as well as neighborhood and environmental factors in relation to cancer risk. She is a Professor and Chief of the Cancer Epidemiology Division in the Department of Epidemiology and Biostatistics at the University of California, San Francisco. She is also a co-Investigator of the SEER Greater Bay Area Cancer Registry.

Joshua, Spin, MD, PhD, is a Clinical Assistant Professor of Cardiology at Stanford University, and a Staff Cardiologist at the Palo Alto VA. In addition to his clinical work at Stanford Hospital and the VA, he is a member of the Stanford Center for Inherited Cardiovascular Disease and the Stanford Cardiovascular Institute, and is also an attending physician in the Stanford Marfan Center. Dr. Spin's laboratory conducts basic and translational research in vascular biology, with an emphasis on investigations of abdominal aortic ananeurysmsnd vascular smooth muscle cells.

Dr. Linda Geng, MD, PhD is a Clinical Assistant Professor of Medicine whose clinical focuses include diagnostic medicine, undiagnosed diseases, medical mysteries, rare disorders, post-acute COVID-19 syndrome (long COVID), and internal medicine. She is the Co-Director of Stanford’s Consultative Medicine Clinic and Co-Director of Stanford’s Post-Acute COVID-19 Syndrome Clinic.

Dr. Andrew Li, MD is a fellow in the division of Gastroenterology and Hepatology at the Stanford University School of Medicine. His research interests are in gastrointestinal cancers, precision medicine, and therapeutic endoscopic procedures.

Dr. Rona Hu, MD, is the Medical Director of the Acute Psychiatric Inpatient Unit at Stanford Hospital, specializing in the care of those with serious mental illnesses, including schizophrenia, bipolar, and depression. She completed medical school and residency in psychiatry at the University of California, San Francisco, and fellowships in Pharmacology and Schizophrenia Research through the National Institutes of Health. She is also active in minority issues and cultural psychiatry and has received regional and national recognition for her clinical care, research, and teaching.

Dr. Latha Palaniappan MD, MS, is an internist and clinical researcher. Her research has focused on the study of diverse populations, chronic disease, and prevention. Dr. Palaniappan specifically seeks to address the gap in knowledge of health in Asian subgroups and other understudied racial/ethnic minorities. During her time at Palo Alto Medical Foundation (PAMF) as the Medical Director of Clinical Research, she led the organization-wide initiative to collect patient race/ethnicity and language information, enabling PAMF researchers to conduct disparities research using electronic health records. She was the co-founder of PRANA, a South Asian Wellness program. Her current work examines the clinical effectiveness of structured physical activity programs for diabetes management, as well as best exercise regimens for normal-weight diabetics. She was recently awarded a Midcareer Investigator Award by the National Institutes of Health to provide mentoring to junior clinical investigators in the conduct of patient-oriented research. She is currently working on implementation of evidence based genetic and pharmacogenetic testing in Primary Care Clinics as the Scientific Director of Precision Genomics and Pharmacogenomics in Primary Care. She is the Faculty Co-Director of the Stanford Biobank, designed to accelerate translatable scientific discoveries. She co-founded the Center for Asian Health Research and Education (CARE) at Stanford in 2018.

Fumiaki Ikeno, MD, is a Research Associate in Cardiovascular Medicine at Stanford University and the Program Director (U.S) Japan Biodesign, Stanford Biodesign.